Oura, the Finnish health technology company behind the Oura smart ring, has postponed its planned initial public offering on the Nasdaq, citing uncertainty in the market for new offerings.

The startup and its shareholders had sought to raise as much as $2.2 billion through the US IPO. The offering was reportedly about four times oversubscribed. Oura had planned to price the deal on Tuesday and begin trading on Wednesday, but instead paused the process entirely. Pausing a heavily oversubscribed deal underscores how much broader market conditions — rather than demand for the shares themselves — have shaped which companies reach the public markets this fall.

Bloomberg reported the delay in a post on X:

Oura will delay its planned IPO on Nasdaq due to uncertainty in the market for first offerings. The startup and its shareholders were looking to raise as much as $2.2 billion in the US IPO, which was about four times oversubscribed. Read more: 📷:… pic.twitter.com/wh4KxVwifH — Bloomberg (@business) September 29, 2026

“Our mission is to empower people to live healthier, longer, and an IPO is just one step in our journey,” Oura CEO Tom Hale said in a statement. He added that the company has “the luxury of choosing our moment.”

The offering covered 50 million shares priced between $40 and $44 each. At the top of that range, Oura would have raised approximately $2.2 billion and received a fully diluted valuation of close to $15.62 billion.

Broader IPO market uncertainty

Several factors have weighed on the IPO market this fall. Rising bond yields have made investors more selective when assessing growth-company valuations, while the Federal Reserve’s recent interest-rate hike has added further pressure. Investors are also questioning how much longer the artificial intelligence trade can continue driving markets higher. That backdrop has raised the bar for first-time listings, and Oura’s pause shows that even a solid order book has not been enough to carry a deal through to pricing in current conditions.

Oura’s decision follows similar moves by other companies. Nuclear services company Holtec suspended its IPO plans earlier this month, while Bamboo Insurance also delayed its listing.

Although demand for Oura’s shares remained solid, reports that the offering was roughly four times oversubscribed were described by one analyst as decent but not overwhelming for a well-known consumer brand.

Attention in the IPO market is now shifting toward AI lab Anthropic. Reports suggest the company could go public after the November midterm elections and potentially become one of the largest public offerings on record.

Oura’s financial and subscription growth

The IPO delay came despite strong reported business performance. Oura generated $1.2 billion in revenue during the nine months ended in June, an increase of roughly 75% from the same period a year earlier. The company also reported pretax earnings of $107 million for that period, excluding noncash charges.

Oura forecast that its revenue would increase by 90% in the full 2026 fiscal year compared with the previous year. Its rings retail for between $400 and $500, while an annual subscription costs $70. The subscription provides access to sleep tracking, temperature data, oxygen-level measurements and guidance from an AI health adviser. That hardware-plus-subscription structure turns each device sale into an ongoing revenue relationship, which is reflected in the renewal and membership figures the company reported.

The company said its average subscription renewal rate is 85% and that women account for more than 70% of its subscribers. Founded more than a decade ago in Finland, Oura reached a valuation of approximately $11 billion in a private funding round last year. The planned IPO valuation would therefore have represented an increase from that figure.

Oura also said its newest device, the Oura Ring 5, has performed well since its launch. Paid membership on the platform has grown to 5.7 million people.

The company has not provided a new timetable for proceeding with the public offering. Until it does, Hale’s description of the “luxury of choosing our moment” captures where Oura stands: reported fundamentals that were strong heading into the filing, a deal that drew demand, and a listing that now waits on market conditions rather than on the company’s own performance.

Source: CoinCentral